Form D · Biotechnology
Owl Biomedical, Inc.
Santa Barbara, CA · CIK 0001509276
Offering snapshot reported Jan 23, 2012 · SEC filing
- Reported sold
- $3M Offering amount: $16.9M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 6, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 23, 2012 | Initial | $3,000,000 | No comparison | 0 | SEC filing |
| Jan 11, 2011 | Initial | $1,125,007 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $210K
- Finders' fees
- $0
- Form D file number
- 021-172265
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Ledgemont Securities, LLC | None |
Source: Form D, filed Jan 23, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Chao | Director |
| John Stuart Foster | Director, Executive |
| James Paul Linton | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
75 Robin Hill Road
Santa Barbara, CA, 93117
Santa Barbara, CA, 93117